Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

IPC 2023 Think Tank Meeting Report Published in JID Innovations

Key highlights from the 2023 International Psoriasis Council (IPC) Think Tank Meeting have been published in JID Innovations, summarizing presentations from the Gunnar Lomholt Symposium in the Faroe Islands. Covering a diverse range of topics related to psoriasis research and treatment strategies, the report underscores the evolving understanding of the genetic basis, comorbidities, pathogenesis, and treatment strategies of psoriasis.

Presentations from the IPC Think Tank meeting offered a comprehensive exploration of historical, current, and future perspectives on psoriasis management, providing valuable insights into its evolutionary trajectory. The future holds promise for a more nuanced understanding as genetic insights, immunological memory, and real-world evidence converge to shape individualized and effective management strategies. In conclusion, the landscape of psoriasis management has shifted from historical genetic explorations to a modern era of data analytics and targeted therapeutics. Navigating this transition involves embracing historical lessons, leveraging current technologies, and advancing toward personalized treatment approaches. As we move forward, the ongoing advancements in psoriasis research and treatment offer hope for alleviating the burden of this chronic condition and improving the quality of life for affected individuals, signifying a significant paradigm shift in psoriasis patient care.

Reference

Proceedings of the Gunnar Lomholt Symposium during the IPC 2023 Think Tank at Faroe Islands, Friday, September 8, 2023. Xing Lai FY, Bachelez H, Gudjonsson J, et al. JID Innovations (2024). doi: https://doi.org/10.1016/j.xjidi.2024.100267.

Comments are closed.

Categories

Recent Posts

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

Fellow Perspectives | Psoriasis Care in Ethiopia: Challenges and Opportunities for Progress

What Matters Most to People with Psoriasis? IPC Members Help Shape a Global Answer

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026